The conflicting role of CD4+T cells has also been reported in NASH–HCC transition, possibly because of the different mouse models used, highlighting the importance of improved animal models of NASH-induced HCC with high fidelity to human pathogenesis. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatohepatitis.